Cargando…
Antihypertensive drugs may not delay the symptom progression of Parkinson’s disease: A 2-year follow-up study
BACKGROUND: Parkinson's disease (PD) is one of the most common neurodegenerative disease, and half of PD patients have hypertension as well. The effect of antihypertensive drugs on the progression of PD has been less studied. The focus of this study was on the changes in dopamine transporter (D...
Autores principales: | Dong, Zhaoying, Zuo, Rui, Zhong, Xiaoni, Zhang, Changhong, Zou, Xiaoya, Tian, Yuan, Zuo, Hongzhou, Du, Xinyi, Yu, Qian, Cheng, Oumei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407028/ https://www.ncbi.nlm.nih.gov/pubmed/37560660 http://dx.doi.org/10.1016/j.heliyon.2023.e18538 |
Ejemplares similares
-
White matter hyperintensities burden in the frontal regions is positively correlated to the freezing of gait in Parkinson’s disease
por: Zou, Xiaoya, et al.
Publicado: (2023) -
Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer’s disease-associated biomarkers alterations among de novo Parkinson’s disease patients: a prospective cohort study
por: Liu, Tingting, et al.
Publicado: (2023) -
Chronic Limb Remote Ischemic Conditioning may have an Antihypertensive Effect in Patients with Hypertension
por: Guo, Wenting, et al.
Publicado: (2021) -
Altered Spontaneous Brain Activity in Patients with Parkinson’s Disease Accompanied by Depressive Symptoms, as Revealed by Regional Homogeneity and Functional Connectivity in the Prefrontal-Limbic System
por: Sheng, Ke, et al.
Publicado: (2014) -
Hypertension, Antihypertensive Use and the Delayed‐Onset of Huntington's Disease
por: Steventon, Jessica J., et al.
Publicado: (2020)